Literature DB >> 21072536

Monitoring prevalence of varicella-zoster virus clades in Germany.

A Sauerbrei1, J Stefanski, A Philipps, A Krumbholz, R Zell, P Wutzler.   

Abstract

The global surveillance of varicella-zoster virus (VZV) clades is an important tool for investigation into viral evolution, host-virus interactions, role of immigration and travel for importation of viral strains as well as possible recombination events between wild- and vaccine-type VZV strains. In this prospective study, comprehensive data on the current distribution of VZV clades in Germany were collected. VZV strains from 213 patients with varicella and 109 with zoster were genotyped using the scattered single-nucleotide polymorphism method on the basis of sequencing open reading frames 1, 21, 22, 37, 50, 54 and 60. In varicella, clade 3 was detected in 45.5%, clade 1 in 30.0%, clade 5 in 21.1% and clade 2 in 0.9% of the cases. The analysis of zoster strains revealed clade 3 in 50.5%, clade 1 in 46.8%, clade 2 and clade 4 in 0.9% of the cases each. Five strains from varicella and one strain from zoster could not be attributed to any of the major and provisional VZV clades. Statistical analysis verified significantly lower frequency of clade 1 and significantly higher frequency of clade 5 in patients with varicella compared to zoster. In addition, varicella patients with clade 5 strains were significantly younger than the patients with clade 3. In conclusion, almost one half of VZV infections in Germany were caused currently by VZV clade 3. In primary VZV infection, nearly 20% of clade 1 has been replaced by clade 5 that might spread more effectively in the population than the European VZV clades.

Entities:  

Mesh:

Year:  2010        PMID: 21072536     DOI: 10.1007/s00430-010-0178-6

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  34 in total

Review 1.  Molecular studies of Varicella zoster virus.

Authors:  Mark Quinlivan; Judith Breuer
Journal:  Rev Med Virol       Date:  2006 Jul-Aug       Impact factor: 6.989

2.  Age related seroprevalence of antibodies to varicella in India.

Authors:  M R Lokeshwar; A Agrawal; S D Subbarao; M S Chakraborty; A V Ram Prasad; J Weil; H L Bock; S Kanwal; R C Shah; N Shah
Journal:  Indian Pediatr       Date:  2000-07       Impact factor: 1.411

3.  Seroprevalence of varicella-zoster virus in the German population.

Authors:  P Wutzler; I Färber; S Wagenpfeil; H Bisanz; A Tischer
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

4.  Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain.

Authors:  Vladimir Loparev; Elisa Martro; Elena Rubtcova; Carlos Rodrigo; Jean-Charles Piette; Eric Caumes; Jean-Paul Vernant; D Scott Schmid; Anne-Marie Fillet
Journal:  J Clin Microbiol       Date:  2006-11-29       Impact factor: 5.948

5.  Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.

Authors:  N Sengupta; Y Taha; F T Scott; M E Leedham-Green; M Quinlivan; J Breuer
Journal:  J Infect Dis       Date:  2007-08-29       Impact factor: 5.226

6.  Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.

Authors:  Barbara Uebe; Andreas Sauerbrei; Stefan Burdach; Gerd Horneff
Journal:  Eur J Pediatr       Date:  2002-06-25       Impact factor: 3.183

7.  Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster.

Authors:  E Puchhammer-Stöckl; T Popow-Kraupp; F X Heinz; C W Mandl; C Kunz
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Genotypes of varicella-zoster virus wild-type strains in Germany.

Authors:  A Sauerbrei; R Zell; A Philipps; P Wutzler
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

9.  The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades.

Authors:  Timothy R Wagenaar; Vincent T K Chow; Chantanee Buranathai; Pranee Thawatsupha; Charles Grose
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

10.  Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003.

Authors:  Michael J Carr; Grace P McCormack; Brendan Crowley
Journal:  J Med Virol       Date:  2004-05       Impact factor: 2.327

View more
  8 in total

Review 1.  Recent publications in medical microbiology and immunology: a retrospective.

Authors:  H W Doerr; J Cinatl
Journal:  Med Microbiol Immunol       Date:  2011-10-29       Impact factor: 3.402

2.  Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.

Authors:  Andrea Streng; Johannes G Liese
Journal:  Transl Pediatr       Date:  2014-10

3.  Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.

Authors:  Ui Yoon Choi; Dong Ho Huh; Jong Hyun Kim; Jin Han Kang
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

4.  Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination.

Authors:  Roland Zell; Stefan Taudien; Florian Pfaff; Peter Wutzler; Matthias Platzer; Andreas Sauerbrei
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 5.  Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections.

Authors:  A Sauerbrei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

6.  Varicella Outbreak in an Indian Couple Living in Germany Caused by VZV Clade VI Acquired during a Trip to The Netherlands.

Authors:  Malgorzata Kolesnik; Bernd Bonnekoh; Ina Tammer; Harald Gollnick; Andreas Sauerbrei
Journal:  Case Rep Med       Date:  2012-03-14

7.  Use of oral fluid to examine the molecular epidemiology of varicella zoster virus in the United Kingdom and continental Europe.

Authors:  Mark Quinlivan; Nitu Sengupta; Vassiliki Papaevangelou; Andreas Sauerbrei; Lena Grillner; Rossitsa Rousseva; Rosie Hague; Irja Lutsar; Piia Jogi; Ana Leca; Ruth Grytchol; Sophie Alain; Judith Breuer
Journal:  J Infect Dis       Date:  2012-10-19       Impact factor: 5.226

8.  Rates of vaccine evolution show strong effects of latency: implications for varicella zoster virus epidemiology.

Authors:  Lucy A Weinert; Daniel P Depledge; Samit Kundu; Anne A Gershon; Richard A Nichols; Francois Balloux; John J Welch; Judith Breuer
Journal:  Mol Biol Evol       Date:  2015-01-06       Impact factor: 8.800

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.